NYLIM
NUVL

New York Life Investment Management’s Nuvalent NUVL Stock Holding History

New York Life Investment Management’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$554K Buy
+5,411
New +$551K ﹤0.01% 747

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

New York Life Investment Management's NUVL Position: Q1 2026 in Review

New York Life Investment Management opened a new position in Nuvalent (NUVL) in Q1 2026: 5,411 shares worth $554K. The stake represents ﹤0.01% of the portfolio and ranks #747 among its holdings.

263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • New York Life Investment Management held 5,411 shares of Nuvalent worth $554K as of Q1 2026.
  • Nuvalent was a new New York Life Investment Management position in Q1 2026.
  • Nuvalent made up ﹤0.01% of New York Life Investment Management's portfolio in Q1 2026, its #747 holding.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.